KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other financing activities: 2010-2025

Historic Other financing activities for Regeneron Pharmaceuticals (REGN) over the last 4 years, with Mar 2025 value amounting to -$10.3 million.

  • Regeneron Pharmaceuticals' Other financing activities was N/A to -$10.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$43.7 million, marking a year-over-year change of. This contributed to the annual value of -$33.4 million for FY2024, which is N/A change from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Other financing activities stood at -$10.3 million for Q1 2025, which was up 69.16% from -$33.4 million recorded in Q3 2024.
  • Regeneron Pharmaceuticals' Other financing activities' 5-year high stood at -$10.3 million during Q1 2025, with a 5-year trough of -$33.4 million in Q3 2024.
  • For the 2-year period, Regeneron Pharmaceuticals' Other financing activities averaged around -$21.9 million, with its median value being -$21.9 million (2024).